The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain

The N-methyl-D-aspartate glutamate receptor (NMDAR) has been implicated in preterm brain injury (periventricular leukomalacia (PVL)) and represents a potential therapeutic target. However, the antagonist dizocilpine (MK-801) has been reported to increase constitutive neuronal apoptosis in the develo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Manning, Simon M., Boll, Griffin, Fitzgerald, Erin, Selip, Debra B., Volpe, Joseph J., Jensen, Frances E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3282022/
https://ncbi.nlm.nih.gov/pubmed/21624454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijdevneu.2011.05.005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak